Patent · US Active

Substituted quinoline derivatives

US7452996B2 · kind B2 · utility

0Cited by

4References

33Claims

0Family size

Assignee

Novartis Vaccines and Diagnostics, Inc. · US

Inventors

Weibo Wang · Moraga, US
Ryan Constantine · Oakland, US
Liana Lagniton · Berkeley, US
Kenneth W. Bair · Chapel Hill, US

Key dates

Filing date	May 19, 2005
Grant date	Nov 18, 2008
Priority date	—
Expiry date	Jan 20, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D215/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.